Brand-name drug · melanocortin receptor agonist

Vyleesi (bremelanotide)

From the FDA label, read Published by PepVault

Vyleesi is bremelanotide, the peptide known in research as PT-141, sold by Cosette Pharmaceuticals as a single-dose autoinjector used only when needed.

FDA approved it for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD): low sexual desire that causes marked distress or difficulty in a relationship and is not explained by another condition, relationship problems or a medicine.

Active ingredient
PT-141
Maker
Cosette Pharmaceuticals
Class
melanocortin receptor agonist
FDA application
NDA 210557, first approved 2019

What FDA approved it for

Acquired means the low desire began after a time without problems; generalized means it happens regardless of situation or partner. The label rules out postmenopausal women and men, and says Vyleesi is not for enhancing sexual performance.

From the label: 2.1 Recommended Dosage; 1 Indications and Usage.

How it is supplied

Vyleesi’s forms and the doses each one gives, as the label lists them
FormDoses
Single-dose autoinjector1.75 mg

From the label: 3 Dosage Forms and Strengths.

The label’s dosing schedule

This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.

Vyleesi, as needed

Vyleesi, as needed: one dose on the label, 1.75 mg.
DoseWhen, on the label
1.75 mg a doseAs needed, at least 45 minutes before sexual activity; at most one dose in 24 hours and 8 a month

There is no climb: every dose is the same 1.75 mg, from the first. Few women in the trials used more than 8 doses a month, and the label adds that using it more often raises the chance of darkened skin patches and lengthens the time each month with raised blood pressure.

From the label: 2.1 Recommended Dosage.

How it’s taken

Vyleesi is injected under the skin of the belly or thigh when needed, at least 45 minutes before expected sexual activity. The label says how long each dose works is unknown, and leaves the timing to each woman’s own experience of it.

The limits are firm: no more than one dose in 24 hours, because doses close together may add to the rise in blood pressure, and no more than 8 doses a month.

If there is no improvement after 8 weeks, the label says to stop.

From the label: 2.1 Recommended Dosage; 2.2 Discontinuation of VYLEESI.

A smiling woman in a dark training top in her kitchen, holding a glass of water

PepVault for iPhone

Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

If a dose is missed

Vyleesi is used as needed, so its label has no missed-dose rule.

Storage

Vyleesi is stored at or below 77°F, out of light, and never frozen.

From the label: 16 How Supplied / Storage and Handling.

Side effects and warnings

Adverse reactions in at least 2% of women on Vyleesi and more often than on placebo, pooled phase 3 trials. Percent of people.
ReactionPlacebo1.75 mg
Nausea1.340.0
Flushing0.320.3
Injection site reactions8.413.2
Headache1.911.3
Vomiting0.24.8
Cough1.33.3
Fatigue0.53.2
Hot flush0.22.7

Nausea was the most common reaction, in 40% against 1% on placebo; it usually began within an hour of the dose and lasted about two hours. In the trials, 18% stopped Vyleesi because of side effects, against 2% on placebo.

The other warnings

Vyleesi has no boxed warning. Its label warns that each dose briefly raises blood pressure and lowers heart rate, peaking 2 to 4 hours after the dose, so it is not for people with uncontrolled high blood pressure or known heart disease. It also warns of darkened patches of skin (focal hyperpigmentation) and of nausea, and says to avoid naltrexone taken by mouth, whose levels Vyleesi can lower.

From the label: 6.1 Clinical Trials Experience; 5 Warnings and Precautions.

What else we have on bremelanotide

Questions about Vyleesi

What is the dose of Vyleesi?

The label’s dose is 1.75 mg injected under the skin of the belly or thigh, as needed, at least 45 minutes before sexual activity. A prescriber decides whether it fits.

How often can Vyleesi be used?

No more than one dose in 24 hours and no more than 8 doses a month, according to the label.

Is Vyleesi the same as PT-141?

Vyleesi’s active ingredient is bremelanotide, the peptide known in research as PT-141; Vyleesi is the FDA-approved product made to its label.

What is the most common side effect of Vyleesi?

Nausea, in 40% of women in the trials against 1% on placebo, usually starting within an hour and lasting about two hours.

Is Vyleesi approved for men?

No. Its label says it is not for men or for postmenopausal women, and not for enhancing sexual performance.

Sources

PepVault is not affiliated with Cosette Pharmaceuticals. Vyleesi is a trademark of its owner.

PepVault for iPhone

Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo